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Abstract
The 3-dimensional (3D) printing technologies, referred to as additive manufacturing (AM) or rapid prototyping (RP),
have acquired reputation over the past few years for art, architectural modeling, lightweight machines, and tissue
engineering applications. Among these applications, tissue engineering field using 3D printing has attracted the
attention from many researchers. 3D bioprinting has an advantage in the manufacture of a scaffold for tissue
engineering applications, because of rapid-fabrication, high-precision, and customized-production, etc. In this
review, we will introduce the principles and the current state of the 3D bioprinting methods. Focusing on some of
studies that are being current application for biomedical and tissue engineering fields using printed 3D scaffolds.
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Background
The conception of 3-dimensional (3D) printing tech-
nologies was first introduced in 1986 by Charles W. Hull
[1]. It referred to as additive manufacturing (AM) or
rapid prototyping (RP) has acquired reputation over the
past few decades [2–4]. 3D printing is one of the addi-
tive manufacturing processes [5, 6]. 3D printing is a
proper name to describe the technologies that create 3D
structures by adding layer-by-layer of material, whether
the material is ceramic, metal, plastic, and polymers
(synthetic or natural polymers) [7]. The steps involve in
product development using 3D printing are shown in
Fig. 1. The 3D printing technologies are commonly used
by the computer, 3D modeling software (computer-aided
design (CAD) or computer tomography (CT) scan
images), machine equipment and layering materials
[8]. After CAD sketch, 3D printing equipment reads
out data from the CAD file and then 3D structure is
produced [9].
Typically, ASTM (F2792) standard terminology for 3D
printing (additive manufacturing) technologies consists
of several parts such as vat photopolymerization, mater-
ial jetting, material extrusion, powder bed fusion, binder
jetting, sheet lamination, and directed energy deposition
as shown in Table 1 [10]. Briefly, the 3D printing of vat
photopolymerization method has a container with a
photopolymer resin and which is then hardened with
ultraviolet (UV) light or another similar power source.
The most commonly used technology in this process is
the Stereolithography Apparatus (SLA) and the Digital
Light Processing (DLP) [11, 12]. This method uses a vat
of liquid photopolymer resin and UV laser to create the
3D structures one at a time. The material is fed through
a nozzle with a small diameter in material injection
process, and the operating behavior is analogous to the
typical inkjet printer. It is produced the 3D structure to
the layer-by-layer, and then cured by UV light [13]. The
binder jetting process uses a liquid binding agent and a
powder-based material. The print-head selectively drops
the liquid binding agent into the powder materials for
3D structure. In addition, this process can print a variety
of materials such as metals, ceramics, and polymers [14,
15]. The most commonly used technology in the mater-
ial extrusion process is the Fused Deposition Modeling
(FDM) [16, 17]. The representative method of FDM is
the Fused Filament Fabrication (FFF). The FFF technol-
ogy is the most common and simplest 3D printing. It
uses thermoplastic filament as the printing material. The
filament is melted in the head of the 3D printer through
heating and then creates 3D structures by adding layer-
by-layer. In the powder bed fusion process, generally
used technology is the Selective Laser Sintering (SLS)
* Correspondence: chkim@kcch.re.kr
†Equal contributors
Laboratory of Tissue Engineering, Korea Institute of Radiological and Medical
Sciences, 215-4, Gongneung, Nowon, Seoul 139-240, Korea
© 2016 Gu et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Gu et al. Biomaterials Research  (2016) 20:12 
DOI 10.1186/s40824-016-0058-2
[18, 19]. During the SLS process, small particles (pow-
der) of polymer, glass, or ceramic are fused together by
heat from a high power laser to form a 3D structure.
The sheet lamination technology is to include different
materials in the sheet by using external force. Sheets
may be used the metal, plastic, polymer, etc. [20, 21].
During the sheet lamination process, the sheet is lami-
nated together using heat and pressure, and then cut
into the desired shape with a laser or blade. Finally, the
directed energy deposition process is mostly used in the
high-tech metal industries and in rapid manufacturing
applications [22, 23]. This printing apparatus consists of
a multi-axis robotic arm with a nozzle, an energy source
(laser, electron, or plasma), and a substrate for deposits
melted material. For creating a 3D structure, the melted
materials by the energy source are deposited on the sub-
strate through nozzles, and then harden.
Recently, the aim of tissue engineering is regeneration,
restoration, or replacement of defective or injured func-
tional living organs and tissues [24–26]. In order to
achieve this aim, biomedical scaffolds made of natural or
synthetic polymers have been commonly used in bio-
medical and tissue engineering applications [27, 28]. The
major focus of these scaffolds is to replace or regenerate
the native tissues functionally and structurally. In gen-
eral, the scaffolds for use as tissues and organs have a
several mandatory functions: it should provide internal
pathways for the cell attachment and migration, it must
transfer various growth factors and waste products, and
it should keep its shape while the cells are growing, and
have adequate mechanical properties. [29]. To achieve
these functions, biomedical scaffolds for tissue engineer-
ing require a highly porous 3D structure that allows cell
affinity such as proliferation, migration, attachment, and
differentiation, even enables nutrients and oxygen trans-
port [30, 31]. Therefore, 3D bioprinting technology is
one of the most appropriate methods for producing a
3D structure for use as biomedical scaffolds, tissues, and
organs. The 3d bioprinting is the technique for control-
ling a cell pattern to be retained functionality and viabil-
ity of the cells within the printed 3D structure. In tissue
engineering, development of the appropriate scaffold
using a 3D printing has already been studied by many
researchers [32, 33]. Advances introduced by 3D bio-
printing have importantly enhanced the ability to control
pore size distribution, pore volume, and pore intercon-
nectivity of scaffolds. Furthermore, 3D bioprinting ac-
credit to important advances in tissue engineering field
by the study of biomaterials or bio-ink. Development of
biomaterials in 3D bioprinting is an important pre-
requisite to a direct effect on cell growth. Some 3D
printing processes to contain living cells and bioactive
molecules in biomaterials (hydrogels) made successfully
3D structures at room temperature without any signifi-
cant effect on the cell viability. For applications using
3D bioprinting technologies in tissue engineering, re-
searchers should be considered the biomaterials (bio-
ink) as well as the 3D structure (design).
Among additive manufacturing technologies, several
methods such as SLA [34, 35], FFF [36, 37], SLS [38, 39]
and inkjet 3D printing [40, 41], etc. have been applied in
tissue engineering field. These methods have been used
in various sectors as architectural modeling, art, and
lightweight machines and also 3D structures from bio-
materials is used for tissue engineering and regenerative
medicine. 3D bioprinting is to produce a 3D structure of
the desired shape by combining the living cells and bio-
materials. Researchers are developing various methods
to fabricate 3D unique structure with biological and
mechanical properties suitable for regeneration of native
tissue. In this review, we describe the four different type
of 3D bioprinting technology for fabrication of 3D struc-
ture and its application in tissue engineering and regen-
erative medicine fields.
Review
3D bioprinting for tissue engineering application
3D Bioprinting form biomaterials are an emerging tech-
nology which aims to develop new organs and tissues.
This technology is currently in research phase, and many
Fig. 1 The 3D printing process. (step-by-step)
Table 1 ASTM standard terminology for additive manufacturing
technologies
Additive Manufacturing (ASM F2792)
Vat photopolymerization • Stereolithography (SLA)
• Digital light processing (DLP)
Material jetting • Multi-jet modeling (MJM)
Material extrusion • Fused deposition modeling (FDM)
Powder bed fusion • Electron beam melting (EBM)
• Selective laser sintering (SLS)
• Selective heat sintering (SHS)
• Direct metal laser sintering (DMLS)
Binder jetting • Powder bed and inkjet 3D printing (PBIH)
• Plaster-based 3D printing (DMLS)
Sheet lamination • Laminated object manufacturing (LOM)
• Ultrasonic consolidation (UC)
Directed energy deposition • Laser metal deposition (LMD)
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researchers have conducted a study. 3D bioprinting is a
process for controlling the cell proliferation, attachment,
and migration within 3D structures [42, 43]. Therefore,
various 3D bioprinting methods are used for a variety of
tissue engineering applications. Herein, we will introduce
the four types of 3D bioprinting methods that are most
commonly used such as SLA and DLP in vat photopoly-
merization, FFF in material extrusion, SLS in powder
bed fusion, and inkjet 3D printing in binder jetting
methods. Table 2 shows advantages and disadvantages of
various 3D bioprinting methods for tissue engineering
applications.
Vat photopolymerization method
SLA method using the UV light is one of the various
methods used to create the 3D structures. This method
has been the oldest and still widely used. This process
has obtained the patent in 1986 by Charles Hull [1].
Also, DLP is similar to the SLA method. The main dif-
ference of the DLP is to use a visible light source, such
as a liquid crystal display panel and an arc lamp. SLA
and DLP are based on the vat photopolymerization
principle of photosensitive monomer resins when ex-
posed to UV light or another similar power source.
Photopolymerization is driven by a chemical reaction
that produces free radicals when exposed to certain
wavelengths of light. Photons from the light source dis-
sociate the photoinitiator to a high energy radical state.
The radical induces the polymerization of the macromer
or monomer solution. However, the problem with this
photopolymerization process is that the created free rad-
icals can have damage to the cell membrane, protein,
and nucleic acids. Therefore, it is important to find a
cytocompatible photo-initiator for the SLA 3D printing
method. A typical schematic of vat photopolymerization
method is shown in Fig. 2(a). To obtain the 3D scaffold
for tissue engineering application, many researchers re-
ported the SLA product with various biomaterials.
Neiman et al. have fabricated composite 3D structures
with photopolymerizable PEG based hydrogel scaffolds
using SLA based process. The aim of this study was
development to foster formation of 3D liver aggregates
and microperfusion flow within the open channels of
this structure [44]. Elomaa et al. showed that they
used the L-alanine-derived depsipeptide to synthesize
a new biodegradable, photopolymerizable poly(ethyl-
ene glycol-co-depsipeptide) macromer for the DLP-
based fabrication of cell-laden hydrogel constructs for
vascular applications [45]. In addition, they (Elomaa et
al.) also reported that three-armed polycaprolactone
(PCL) oligomers of various molecular weights were
synthesized, end-functionalized with methacrylic an-
hydride and photopolymerized. PCL-based photopoly-
merizable and biodegradable resins were formulated
and used without solvents in SLA to accurately pre-
pare designed porous 3D scaffolds [46]. In resulting
3D scaffolds, they have explained that 3D structures
with a high porosity have a great potential in the cell
culture and implanting. Chan et al. introduced that cell
encapsulated hydrogel with a complex 3D structure was
created from photo-polymerizable poly(ethylene glycol)
diacrylate (PEGDA) using modified SLA method [47].
In the result, NIH/3 T3 cells-encapsulated within 3-
Dimensional structures were successful, and it was
confirmed that the cells are excellent in affinity (cell
viability, proliferation and spreading). Seck et al. de-
scribed the synthesis of poly(ethylene glycol)/poly(D,L-
lactide) based macromers, the resin formulation, and
the photo-polymerization process by DLP that allows
the generation of designed 3D crosslinked structures
[48]. The fabricated porous hydrogel structure showed
narrow pore size distributions, excellent pore inter-
connectivity and enhanced mechanical properties. The
human mesenchymal stem cells on this 3D structure
exhibit a characteristic of superior cell adhesion and
proliferation.
Table 2 Advantages and disadvantages of various 3D bioprinting methods for tissue engineering applications
Methods Advantages Disadvantages Materials Ref.
SLA, DLP • Manufactured simple and complex • Expensive equipment and materials PEG, PCL, PEG-co-PDP, PEGDA. [45–48]
• Fast and good resolution • Only photopolymers
• No need for support materials • Cytotoxicity of uncured photoinitiator
FFF • Easy to use • Materials limited to thermoplastics PCL/PLGA/β-TCP, PCL/PLGA [50, 51]
• Good mechanical properties • Filament required
• Solvent not required • Cannot used with cells
SLS • No need for support materials • Rough surface PCL/HA, PCL, HA/PEEK, Titanium. [59–62]
• Various of biomaterials • Expensive and cumberstone equipment
Inkjet • Cells and hydrogel printed • Limited biomaterials suite Collagen/PDL, Fibrin, Gelatin. [63–65, 68]
• Incorporation of drug and biomolecules • Low resolution
• Low mechanical properties
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The main advantages of vat photopolymerization
method in tissue engineering applications are that
fabrication of simple, complex designs, fast processing,
high resolution, and no need for support material. The
disadvantages are that expensive equipment, expensive
curing materials as photoinitiator, and cytotoxicity of
uncured photoinitiator.
Fused filament fabrication method
FFF printers in material extrusion method use a thermo-
plastic filament. This filament is heated to the melting
point and then extruded to prepare a 3D structure.
These thermoplastic filaments are deposited through an
extrusion nozzle during printing. The nozzle melts the
filaments and then extrudes onto the substrate for
fabricating 3D structure (FFF method). The nozzle and
substrate are controlled by a computer that translates
the dimensions of a structure into X, Y and Z coordi-
nates during printing. A schematic of material extrusion
method is shown in Fig. 2(b). FFF method is a thermal-
heating technique for use 3D scaffolds fabrication in
tissue engineering applications. Many researchers were
reported using FFF method for tissue engineering. Pati
et al. reported that to enhance the biological properties
of extracellular matrix (ECM)-ornamented 3D printed
scaffolds with cells using FFF bioprinting [49]. They de-
veloped bone graft substitutes by using 3D printed
scaffolds made from a composite of polycaprolactone
(PCL), poly(lactic-co-glycolic acid) (PLGA), and β-trical-
cium phosphate and mineralized ECM laid by human
nasal inferior turbinate tissue-derived mesenchymal
stromal cells. Lee et al. fabricated melt-plotted/in situ
plasma-treated PCL scaffolds coated with chitosan of
various molecular weights in a layer-by-layer manner
[50]. They evaluated the effects of the chitosan coating
on various physical and cellular activities, including
water wetting ability, cell proliferation, ALP activity, and
calcium deposition using the osteoblast-like MG63 cell
line. Hong et al. fabricated solid freeform fabrication
based 3D PCL/PLGA scaffolds that provide functional-
ized surfaces through a simple but efficient coating of
mussel adhesive proteins without any surface modifica-
tion procedures [51].
The main advantages of FFF method in tissue engin-
eering applications are that easy to use, a variety of bio-
materials, good mechanical properties, and the solvent
not required. The disadvantages are material restriction
related to thermoplastic polymers. In addition, it cannot
be printed with the cells due to the high manufacturing
temperature.
Selective laser sintering method
SLS is a technique that uses the laser as a power source
to form solid 3D structures. This method uses a high
Fig. 2 Schematics of various 3D bioprinting for tissue engineering applications; a Vat photopolymerization, b Fused filament fabrication, c Selective
laser sintering, d Inkjet 3D printing
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power laser for powder sintering to form a scaffold. This
method is produced by selective laser printing from 3D
modeling software in the part on the surface of a powder
bed. This process may be printed from several of mate-
rials such as ceramics, metals, and polymers. A sche-
matic of SLS is shown in Fig. 2(c). SLS of polymer
powder has been evaluated by several groups for tissue
engineering application and drug delivery system [52–
55]. Moreover, the SLS has been used to tissue
engineering application as scaffolds from polymeric
biomaterials and their composites [56–58]. Du et al.
fabricated a novel protocol to produce SLS-derived
bone scaffolds using the PCL microspheres and poly-
caprolactone/hydroxyapatite (PCL/HA) composite mi-
crospheres as the basic building materials [59]. The
biocompatible evaluation of the SLS-derived scaffolds
was investigated using rat MSCs and the results
showed both pure PCL scaffolds and PCL/HA com-
posite scaffolds can well support cell adhesion, prolif-
eration, and growth. Williams et al. used SLS to
process PCL to produce parts with controlled pore
sizes in the range 1.75 ~ 2.5 mm and designed porosi-
ties from 63.1 % to 79 %, but met with limited suc-
cess in terms of accurately achieving the required
porosity levels [60]. Particle size and thermodynamic
variations were found to play critical roles. Tan et al.
demonstrated the ability of SLS to fabricate
physically blended hydroxyapatite/poly(ether-ether-
ketone) composites for tissue scaffold development
and observed micropores on the scaffold surface
[55]. Chen et al. showed that PCL scaffolds manufac-
tured by SLS were surface modified by immersion
coating with either gelatin or collagen for cartilage
tissue engineering [61]. Ciocca et al. reported a tech-
nique to design and manufacture a customized titan-
ium mesh for minimal bone augmentation of an
atrophic maxillary arch, guided by the final position
of the prosthesis and according to the implants ne-
cessary for its support [62].
The main advantages of this process for tissue engin-
eering applications are a wide range of biomaterials that
can be used. Powder bed is used as a support, therefore,
no need for secondary support structures. Also, unused
powders may be recycled. The disadvantage of SLS is
that the detail is not as crisp and sharp when compared
with other processes, such as SLA and FFF. Another dis-
advantage is that the SLS bioprinters tend to be large,
cumbersome, and expensive.
Inkjet 3D printing
Inkjet 3D printing method is a rapid prototyping and
layered manufacturing technology for making structures
described by 3D modeling data. Inkjet 3D printing is
closely related to Inkjet head printing. Lately, inkjet 3D
printing method has been significant developments in
the use of polymeric bio-ink printing for applications in
biological and tissue engineering fields. A schematic of
inkjet 3D printing is shown in Fig. 2(d). Inkjet bioprin-
ters are the most commonly used type of printer for
both non-biological and biological applications. Many
researchers were reported using inkjet head 3D bioprint-
ing method for tissue engineering. Sanjana et al. re-
ported on the use of inkjet bioprinting to create neuron
adhesive patterns as islands and other pattern using PEG
(cell-repulsive material) and collagen/poly-D-lysine
mixture (cell-adhesive material) [63]. Xu et al. use the
inkjet bioprinting technology for the fabrication of 3D
scaffolds, based on fibrin gel [64]. Fibrin has been
used as a printable hydrogel for building a 3D neural
construct. Lee et al. reported the printing of a growth
factor-releasing fibrin gel containing murine neural
stem cells (NSCs) to construct an artificial neural tis-
sue and then examined the effects of the growth
factor-releasing fibrin gel on the survival of the mur-
ine NSCs [65]. Lorber et al. printed retinal glia cells
with cell culture media and subsequently assessed the
survival of these cells in culture [66]. Pati et al. have
focused on bioprinting of dome-shaped adipose tissue
constructs using human decellularized adipose tissue
matrix bio-ink that encapsulates human adipose
tissue-derived mesenchymal stem cells through bio-
mimetic approach for evaluation of their efficacy in
adipose tissue regeneration [67]. Irvine et al. reported
on the development of printable gelatin as the bio-ink
with cell-encapsulated. They were fabricated patterned
3D structure by using inkjet bioprinter and then con-
firmed excellent cell affinity [68].
The advantages of inkjet 3D bioprinting method for tis-
sue engineering applications are that patient-customized
fabrication, rapid production, low cost of production, and
easy to incorporate both drug and biomolecules. In
addition, it can be a printing with the cells. The disadvan-
tages are that limitation of size and biomaterials, low reso-
lution, and negligible mechanical properties.
Current and future direction for 3D bioprinting
The technology for 3D bioprinting has a lot of advan-
tages, but it still has many challenges that remain to be
overcome. Heretofore, several types of research about
3D bioprinting have conducted in the lab of universities
and companies. For example, Organovo’s exVive3D™
Liver bioprinted human tissue models with collagen are
created using proprietary 3D bioprinting technology
[69]. The resulting tissues contain accurate and reprodu-
cible 3D structure that can remain completely functional
and reliable over 40 days. Also, Atala group was suc-
ceeded in scaffold production for the human kidney
using 3D bioprinting technology [42]. Cornell university
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researchers reported that 3D printed ears similar to
human ear using 3D bioprinting and collagen gels with
living cells [70]. So far, as mentioned above, patient-
customized 3D bioprinting was studied only in a few
laboratories. However, 3D bioprinting in the future has
to be the development of various models in many
laboratories.
Additionally, the development of bio-inks (biomate-
rials) in 3D bioprinting is very important for printing
tissue or organs in the future. However, 3D bioprint-
ing processes are limited to scaffolds for cells sup-
port and simple body parts such as bone. Currently,
most of the bio-inks for 3D bioprinting are limited
to collagen, gelatin, fibrin, ceramics, thermoplastics
or light-curable composite. As shown in Table 3, the
range of available bioprinting materials is limited. To
overcome these limitations, the development of new
biomaterials that can be printed with the cells is
necessary. The biomaterials for bioprinting should be
biocompatible, easily manufactured, sufficient mechanical
properties for cells support, secure 3D structure.
The future of 3D bioprinting is not limited to inani-
mate structures. 3D printed medical implants will be
able to enhance the quality of human life. 3D bioprinting
is currently used for prosthetic limbs, orthodontic de-
vices, and bone implants because it can be matched to
the correct body shape of the patient. Printing of soft
tissue is progress, and can be used immediately in veins
and arteries printing operations. Today, medical applica-
tions of 3D bioprinting have developed a nano-medicine,
pharmaceuticals, and organs such as human health
fields. Finally, direct organ fabrication using 3D bioprint-
ing technology is the ultimate goal in tissue engineering
and regenerative medicine. There is a possibility of
printing a complete organ that could be directly trans-
planted into the human body.
Conclusion
In the recent years, a lot of 3D bioprinting method
and design has been developed for tissue engineering.
Especially, computer-aided 3D printing techniques
have a great potential to fabricate complex 3D struc-
tures with highly porosity architecture. It can be
achieved great strides in biomedical application fields,
especially infusion of medical imaging techniques
such as CT and MRI. However, the low resolution
and using only one technology for fabricating a native
tissue similar 3D structure, there is a limit. Thus,
using more than two 3D printing technologies or
combination of 3D printing technologies with other
scaffold fabrication technologies can overcome the
limitations and fabricate a multifunctional 3D struc-
ture. In the recent, only a few of the research groups
have been deeply characterized though extensive in
vitro and in vivo studies and results are mostly lim-
ited to a restricted number of biomaterials. Thus, de-
velopment of materials (bio-ink) is one of the most
important goals in 3D printing. It has enabled to dir-
ectly create implantable devices such as biodegradable
tissue engineering scaffolds.
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